Cathie G. Miller PhD

Director, HBDI at the NDRI

Philadelphia, PA

Specialties and Interests

Microbiology,
Virology,
Immunology,
Cancer Biology

Education

Universities

University of Michigan

BS, Biology

1986 to 1990

University of Louisville

PhD, Microbiology and Immunology

Role of viral complement binding protein in poxviral infection.

Postgraduate Training

University of Pennsylvania

1998 to 2002

Use of Oncolytic Herpes Viral Therapy for Treatment of Intracranial Melanoma: Contribution of the Immune Response to Active Viral Mediate Tumor Destruction

Wistar Instistute

1997 to 1998

Use of Oncolytic Herpes Viral Therapy for Treatment of Intracranial Melanoma

Mentors

Daniel Remick, MD

Pre-doctoral mentor: Understanding and training in laboratory techniques and data analysis.

Girish Kotwal, PhD

Doctoral advisor: Role of viral complement binding protein in poxviral infection.

Jorge L. Rodriguez, MD

Pre-doctoral mentor: Contribution of systemic cytokine imbalance to the development of multiple organ failure in trauma and burn patients.

Nigel Fraser, PhD

Post-doctoral advisor: Contribution of immune response to oncolytic herpes viral therapy of intracranial melanoma.

Publications

Articles

"Splenic and immune alterations of the Sparc-null mouse accompany a lack of immune response."

Genes and immunity

Vol. 8 - 2007;

PubMed ID: 17344888

"Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells."

Cancer research

Vol. 66 - 2006;

PubMed ID: 16618735

"Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma."

Neuro-oncology

Vol. 8 - 2006;

PubMed ID: 16723633

"Requirement of an integrated immune response for successful neuroattenuated HSV-1 therapy in an intracranial metastatic melanoma model."

Molecular therapy : the journal of the American Society of Gene Therapy

Vol. 7 - 2003;

PubMed ID: 12788647

"Herpes simplex virus latency-associated transcript gene function."

Journal of neurovirology

Vol. 9 - 2003;

PubMed ID: 12775412

"T1rho imaging of murine brain tumors at 4 T."

Academic radiology

Vol. 8 - 2001;

PubMed ID: 11201456

"Development of a syngenic murine B16 cell line-derived melanoma susceptible to destruction by neuroattenuated HSV-1."

Molecular therapy : the journal of the American Society of Gene Therapy

Vol. 3 - 2001;

PubMed ID: 11237672

"Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo."

Journal of virology

Vol. 76 - 2001;

PubMed ID: 11752162

"Role of the immune response during neuro-attenuated herpes simplex virus-mediated tumor destruction in a murine intracranial melanoma model."

Cancer research

Vol. 60 - 2000;

PubMed ID: 11059765

"The inflammation modulatory protein (IMP) of cowpox virus drastically diminishes the tissue damage by down-regulating cellular infiltration resulting from complement activation."

Molecular and cellular biochemistry

Vol. 185 - 1999;

PubMed ID: 9746210

» Show more

Disclosure or Conflict of Interest

Cathie G. Miller PhD has nothing to disclose

Leave a message on her Wall

Tokens of Appreciation

2 tokens received
What are Tokens of Appreciation?

A Token of Appreciation is a way of acknowledging another member for their contributions to Medpedia. You have 5 Tokens to give per week.

Medpedia Achievements

Editor Level 1 - May 04, 2009

Medpedia

Sign Up or Login